Evogene's total assets for Q4 2023 were $51.10M, a decrease of -8.95% from the previous quarter. EVGN total liabilities were $22.42M for the fiscal quarter, a 3.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.